This inventor holds 1 USPTO granted patent. Top assignees: National Institute of Health and Medical Research, University of Guelph. Active years: 2005.
Company Filing History:
1 out of 1,853 
1 out of 112 
Years Active: 2005
Title: Keith Linder: Innovator in Equine Genetics
Introduction
Keith Linder is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of equine genetics, particularly in the diagnosis of genetic disorders in horses. His work has implications for veterinary medicine and animal health.
Latest Patents
Linder holds a patent for the "Isolation of the lamin γ2 gene in horses and its use in diagnostic junctional epidermolysis bullosa." This patent details the cloning of the laminin γ2 subunit of equine laminin-5 gene, providing both the nucleic acid and corresponding protein amino acid sequence. The patent also outlines a method for diagnosing junctional epidermolysis bullosa in horses, based on the identification of a mutation in the laminin γ2 gene associated with the disease.
Career Highlights
Throughout his career, Keith Linder has worked with prestigious institutions such as the University of Guelph and the National Institute of Health and Medical Research. His research has focused on advancing the understanding of genetic disorders in horses, contributing to improved diagnostic methods.
Collaborations
Linder has collaborated with notable colleagues, including Alexandra Charlesworth and John Baird. These partnerships have enhanced his research efforts and expanded the impact of his work in the field of equine genetics.
Conclusion
Keith Linder's innovative work in isolating the lamin γ2 gene has paved the way for advancements in the diagnosis of genetic disorders in horses. His contributions to veterinary medicine are invaluable and continue to influence the field.